Login

Naifeng Yang

ORCID: 0009-0001-1675-3723
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5036330336
Research Areas
  • Advanced Antenna and Metasurface Technologies
  • Electromagnetic wave absorption materials
  • Gastric Cancer Management and Outcomes
  • Selenium in Biological Systems
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Treatments and Mutations
  • Phytase and its Applications
  • Colorectal Cancer Treatments and Studies
  • Cellular and Composite Structures
  • Esophageal Cancer Research and Treatment
  • Metamaterials and Metasurfaces Applications

National University of Defense Technology
 2024

Central South University
 2023

Hunan Cancer Hospital
 2022-2023

 Excellent angular and electrical performance damage tolerance of wave-absorbing laminate via gradient A-T-A design
OPENALEX - Publications 
Yiming Zhao Suli Xing Qifeng Jin Naifeng Yang Yonglyu He and 1 more Jianwei Zhang

10.1016/j.coco.2024.101838 article EN Composites Communications 2024-02-01
 Frequency insensitive electromagnetic absorption core-shell sandwich structure with excellent electromagnetic damage tolerance
OPENALEX - Publications 
Yiming Zhao Suli Xing Changliang Li Naifeng Yang Yonglyu He and 2 more Ke Duan Jianwei Zhang

10.1016/j.compositesb.2024.111946 article EN Composites Part B Engineering 2024-11-05
 Effects of Different Modes of Selenium-Enriched Yeasts on Production Performance, Gut Microbiology and Multi-Omics of Artemia Tibetiana
OPENALEX - Publications 
Feng Chen Jie Zhang Naifeng Yang Mingyang Wang Tao Zhao and 1 more Hong Ji

10.2139/ssrn.5143082 preprint EN 2025-01-01
 14MO Updated efficacy and safety of taletrectinib in patients (pts) with ROS1+ non-small cell lung cancer (NSCLC)
OPENALEX - Publications 
W. Li Naifeng Yang Kaixu Li H. Fan Q. Yu and 15 more H. Wu Y. Wang Xianying Meng J. Wu Z. Wang Y. Liu X. Wang Xingliang Qin Kexiang Lu W. Zhuang S. He P.A. Janne T. Seto S-H.I. Ou C. Zhou

10.1016/s1556-0864(23)00268-x article EN publisher-specific-oa Journal of Thoracic Oncology 2023-04-01
 P-86 First-line nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients with advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 Chinese subgroup analysis 2-year follow-up
OPENALEX - Publications 
L. Shen Yefei Bai X. Lin Wentan Li Jie Wang and 17 more Xiaomei Zhang Harrison Pan C. Bai Longjian Bai Y. Cheng J. Zhang H. Zhong Y. Ba Wenyu Hu Run-Nan Xu Weijian Guo S. Qin Naifeng Yang J. Lu C. Amaya Chanaga S. Soleymani T. Liu

10.1016/j.annonc.2022.04.176 article EN publisher-specific-oa Annals of Oncology 2022-06-01
Coming Soon ...